Israel Approves 4th Covid Shot for Immunocompromised

1
>>Follow Matzav On Whatsapp!<<

i24 News Israel will start rolling out the fourth shot of the coronavirus vaccine among the immunocompromised, coronavirus czar Prof. Nachman Ash announced on Thursday.

“We will continue to track the data on a daily basis and we will see if we need to broaden this recommendation to more of the population,” he said.

This comes after the Health Ministry approved and then delayed a the second booster shot for Israelis aged 60 and upward, as it reassessed the threat posed by the omicron variant.

Some 4.2 million Israelis out of a population of nearly 9.5 million received three shots of the vaccine.

Earlier in the day, Israel received its first shipment of the Pfizer antiviral Covid pill Paxlovid.

Meanwhile, the infection in the country is surging.

Health authorities reported some 4,000 new cases on Wednesday, a high not seen in several months.

{Matzav.com Israel}


1 COMMENT

  1. IN THE US, THE SUPREME COURT HAS RULED THAT VACCINATED PEOPLE WORLDWIDE ARE PRODUCTS, PATENTED GOODS, ACCORDING TO US LAW, NO LONGER HUMAN.

    In the US, the Supreme Court has ruled that vaccinated people worldwide are products, patented goods, according to US law, no longer human.
    Through a modified DNA or RNA vaccination, the mRNA vaccination, the person ceases to be human and becomes the OWNER of the holder of the modified GEN vaccination patent,
    because they have their own genome and are no longer “human” (without natural people), but “trans-human”, so a category that does not exist in Human Rights.
    The quality of a natural person and all related rights are lost.
    This applies worldwide and patents are subject to US law.
    Since 2013, all people vaccinated with GM-modified mRNAs are legally trans-human and legally identified as trans-human and do not enjoy any human or other rights of a state, and this applies worldwide,
    because GEN-POINT technology patents are under US jurisdiction and law, where they were registered.

LEAVE A REPLY

Please enter your comment!
Please enter your name here